Sturner KH, et al. - In this study, experts sought to examine whether oral administration of a standardised frankincense extract (SFE) was safe and reduced disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). They found oral SFE to be a safe and well-tolerated treatment for these patients. Oral SFE showed beneficial effects on RRMS disease activity justifying further investigation in a controlled phase IIb or III trial.